NCT01397474

Brief Summary

  • Impaired peripheral perfusion is related to worse outcome in critically ill patients. Although this is known, these parameters have never been used as target for hemodynamic therapy.
  • We hypothesize that targeting of fluid administration on parameters of peripheral perfusion might prevent excessive fluid administration, leading to less formation of tissue edema, less respiratory dysfunction and shorter duration of mechanical ventilation in critically ill patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at below P25 for phase_4 sepsis

Timeline
Completed

Started Oct 2011

Typical duration for phase_4 sepsis

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2011

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 19, 2011

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 6, 2014

Status Verified

January 1, 2014

Enrollment Period

2.3 years

First QC Date

July 7, 2011

Last Update Submit

January 3, 2014

Conditions

Keywords

peripheral perfusioncritically ill patientsfluid administration

Outcome Measures

Primary Outcomes (1)

  • Fluid balance during Intensive Care Unit stay

    Total and daily fuid balance for a maximal time period of 72 hours

    untill 72 hours after admission

Secondary Outcomes (6)

  • CRT (Capillary refill time)

    Within 72 hours after admission

  • Systemic hemodynamic variables

    Untill 72 hours after admission to the ICU

  • Respiratory function

    Untill 72 hours after admission to the ICU

  • PFI (Peripheral Flow Index)

    Untill 72 hours after ICU admission

  • Tskindiff (Forearm-to-Fingertip temperature skin difference)

    Untill 72 hours after ICU admission

  • +1 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

The fluid management algorithm of the control group is based on the standard care procedure of our ICU as recommended in guidelines: the patient's fluid status is assessed by performing a fluid challenge with a bolus of 250 ml colloids. When the patients is fluid responsive (i.e. showing an increase in stroke volume \> 10% ) he will receive an additional bolus of 250 ml of colloids. After each fluid challenge, patients will be revaluated for fluid responsiveness to access need of further fluid administration.

PPTFM

EXPERIMENTAL

The fluid management algorithm of the intervention group uses identical therapy (i.e. fluids) yet targeted at different endpoints (i.e. peripheral perfusion parameters). After evaluation of peripheral perfusion, only patients with a "bad peripheral perfusion" (i.e. 3 out of 4 criteria considered as bad) will receive a fluid challenge, the same way as in the standard care procedure (i.e. bolus of 250 ml of fluid). After each fluid challenge, patients will be re-evaluated for peripheral perfusion to access further need in fluid challenges. To ensure that no hypovolemia will occur in the intervention group, fluid will be administered irrespectively of peripheral perfusion parameters, if cardiac index falls below a value of 2,5 L/min/m2.

Other: PPTFM

Interventions

PPTFMOTHER

Peripheral Perfusion Targeted Fluid Management

Also known as: CRT, PFI, delta Temp, StO2
PPTFM

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients (\>18 years) admitted to the intensive care with 1) hemodynamic instability due to severe sepsis, and 2) a mean arterial pressure \< 65 mmHg and 3) an arterial lactate concentration \> 3.0 mmol/L will be considered for participation

You may not qualify if:

  • moribund.
  • severe coagulation disorder (contraindication for central venous catheter placement).
  • severe peripheral vascular disease (interfering with peripheral perfusion measurement).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

ErasmusMC

Rotterdam, South Holland, 3015 CE Rotterdam, Netherlands

RECRUITING

ErasmusMC

Rotterdam, South Holland, 3015 CE Rotterdam, Netherlands

RECRUITING

Related Publications (3)

  • Lima A, Jansen TC, van Bommel J, Ince C, Bakker J. The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients. Crit Care Med. 2009 Mar;37(3):934-8. doi: 10.1097/CCM.0b013e31819869db.

    PMID: 19237899BACKGROUND
  • Lima A, van Bommel J, Sikorska K, van Genderen M, Klijn E, Lesaffre E, Ince C, Bakker J. The relation of near-infrared spectroscopy with changes in peripheral circulation in critically ill patients. Crit Care Med. 2011 Jul;39(7):1649-54. doi: 10.1097/CCM.0b013e3182186675.

    PMID: 21685739BACKGROUND
  • van Genderen ME, Engels N, van der Valk RJ, Lima A, Klijn E, Bakker J, van Bommel J. Early peripheral perfusion-guided fluid therapy in patients with septic shock. Am J Respir Crit Care Med. 2015 Feb 15;191(4):477-80. doi: 10.1164/rccm.201408-1575LE. No abstract available.

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jasper van Bommel, MD, PhD

    Erasmus Medical Center

    STUDY DIRECTOR
  • Michel E Genderen, Drs

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jasper Bommel, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Drs

Study Record Dates

First Submitted

July 7, 2011

First Posted

July 19, 2011

Study Start

October 1, 2011

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

January 6, 2014

Record last verified: 2014-01

Locations